Symbiotec Pharmalab IPO Details:
| Company Name | Symbiotec Pharmalab |
| Exchange | NSE, BSE |
| Share Price | ₹988 |
| Open Date | 24-August-2026 |
| Close Date | 27-August-2026 |
| List Date | 01-September-2026 |
| Face Value | 02 |
| Lot Size | 15 |
About Symbiotec Pharmalab
Symbiotec is a research-driven, science-based pharmaceutical and biotechnology company with a strong global leadership position in Corticosteroid and Steroidal Hormone Active Pharmaceutical Ingredients (APIs). With over 30 years of industry expertise, we have evolved from a Lab-Scale Steroid manufacturer into a fully integrated global platform
In Fiscal 2025, Symbiotec achieved a Global Volume Market Share of Corticosteroids and Steroidal-Hormone APIs. We are the only Indian and global company with a presence across the Top – Ten categories.
for more visit website: Symbiotec Pharmalab
Symbiotec Pharmalab IPO Financials
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
| Assets | 1,780.79 | 1,579.65 | 1,294.79 |
| Total Income | 872.26 | 755.98 | 723.33 |
| Profit After Tax | 109.90 | 96.79 | 100.06 |
| EBITDA | 231.97 | 206.11 | 177.04 |
| NET Worth | 1,158.64 | 821.15 | 720.68 |
| Reserves and Surplus | 1,145.95 | 810.03 | 709.54 |
| Total Borrowing | 387.91 | 540.92 | 247.21 |
| Amount in ₹ Crore |
Allotment Information
| Just One Click Check Allotment Status |
| Visit Website Symbiotec Pharmalab |
Total votes: 0
Poll closed